Astellas Japan is a leading pharmaceutical company dedicated to translating cutting‑edge science into meaningful value for patients. The company focuses on developing innovative therapies across oncology, ophthalmology, urology, immunology, and women's health, addressing conditions with significant unmet medical needs. Through robust research and development programs, Astellas pioneers new healthcare solutions that improve patient outcomes worldwide. As part of a global life‑sciences organization, the company combines scientific excellence with a patient‑centric culture that drives continuous innovation.
The Team Lead of Medical Information (MI) Inquiry-Japan is responsible for direction and strategy, in alignment with the Global MI team, of the Japan Standard Response Development and Escalation Team (Japan MI Team). This team is responsible for developing and maintaining MI content and managing escalations across Astellas products and therapeutic areas in Japan.
Astellas Japan is a leading pharmaceutical company dedicated to translating cutting‑edge science into meaningful value for patients. The company focuses on developing innovative therapies across oncology, ophthalmology, urology, immunology, and women's health, addressing conditions with significant unmet medical needs. Through robust research and development programs, Astellas pioneers new healthcare solutions that improve patient outcomes worldwide. As part of a global life‑sciences organization, the company combines scientific excellence with a patient‑centric culture that drives continuous innovation.
Santen Pharmaceutical